Lawyers want $184M slice of Sutter antitrust settlement

The California Attorney General’s Office and five law firms that sued Sacramento, Calif.-based Sutter Health alleging antitrust violations are seeking 32 percent, or $184 million, of the $575 million settlement that would end the litigation, according to Bloomberg Law

Advertisement

The fees cover the nearly 217,000 hours the law firms spent representing the self-funded plans in the class-action lawsuit, the state attorneys and the United Food & Commercial Workers & Employers Benefit Trust. The 32 percent fee falls within the prevailing range of 25 percent to 40 percent in similar cases, according to the report. 

“Together, we conducted ourselves as a single virtual law firm, efficiently combining the many talents of the various legal professionals that were necessary to successfully represent UEBT and overcome what would soon become a scorched-earth defense by Sutter and the five highly skilled law firms and scores of lawyers that represented it in this litigation,” wrote Richard Grossman, Pillsbury & Coleman partner and co-lead counsel in a fee petition, according to Bloomberg Law

The law firms filed the petition ahead of final approval of the proposed all-cash settlement. The hearing is slated for July 21 in California Superior Court.  

More articles on legal and regulatory issues:
Physician group under federal investigation tries to claw back emails
UnitedHealthcare squeezes competition like a ‘boa constrictor,’ physicians say
New Florida law gives hospitals a shield in COVID-19 suits

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.